Moreover, blockade of interleukin (IL)-6 signaling by anti-IL-6 receptor blocking antibody (MR16-1) restrained the PD-1 signal blockade provoked by severe dermatitis by inhibiting both Th17 cell differentiation and cytotoxic CD8 T cell activation. This evidence concerns the gene IL6 and skin disorder.